Neuronetics Company
Neuronetics develops non-invasive therapies for psychiatric and neurological disorders.
Industry:
Biotechnology, Health Care, Medical Device, Therapeutics
Investment Stage:
N/A
Last Funding Date:
2021
Investors Number:
15
Technology:
Neuromodulation
Last Funding Type:
Post-IPO Equity
Headquarters:
Malvern, Pennsylvania, United States
Founded Date:
2003
Investor Type:
N/A
Funding Status:
IPO
Total Funding:
248400000
Estimated Revenue:
$10M to $50M
Number Of Exists:
N/A
Employee Number:
101-250